Cognios Capital LLC reduced its holdings in Davita Inc (NYSE:DVA) by 4.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,217 shares of the company’s stock after selling 1,013 shares during the period. Cognios Capital LLC’s holdings in Davita were worth $1,194,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Quantamental Technologies LLC purchased a new stake in shares of Davita during the 4th quarter worth about $34,000. Oregon Public Employees Retirement Fund raised its stake in shares of Davita by 4,995.1% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,880,451 shares of the company’s stock worth $37,000 after purchasing an additional 1,843,544 shares in the last quarter. Dupont Capital Management Corp raised its stake in shares of Davita by 41.0% during the 4th quarter. Dupont Capital Management Corp now owns 2,525 shares of the company’s stock worth $130,000 after purchasing an additional 734 shares in the last quarter. Honkamp Krueger Financial Services Inc. purchased a new stake in shares of Davita during the 3rd quarter worth about $143,000. Finally, Caption Management LLC raised its stake in shares of Davita by 100.7% during the 4th quarter. Caption Management LLC now owns 3,200 shares of the company’s stock worth $164,000 after purchasing an additional 488,800 shares in the last quarter. 85.99% of the stock is owned by hedge funds and other institutional investors.

A number of equities research analysts have recently weighed in on the company. Zacks Investment Research raised Davita from a “sell” rating to a “hold” rating in a research note on Thursday. Royal Bank of Canada reissued a “hold” rating and set a $65.00 price objective on shares of Davita in a report on Wednesday, January 9th. Raymond James raised Davita from a “market perform” rating to an “outperform” rating and set a $70.00 price objective on the stock in a report on Wednesday, November 28th. They noted that the move was a valuation call. ValuEngine lowered Davita from a “hold” rating to a “sell” rating in a report on Wednesday, January 2nd. Finally, Barclays assumed coverage on Davita in a report on Friday, December 14th. They set an “overweight” rating and a $70.00 price objective on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $66.41.

Shares of NYSE DVA opened at $58.09 on Friday. The company has a current ratio of 1.84, a quick ratio of 1.82 and a debt-to-equity ratio of 2.09. The stock has a market cap of $9.61 billion, a PE ratio of 16.27, a P/E/G ratio of 0.59 and a beta of 1.31. Davita Inc has a 52 week low of $48.25 and a 52 week high of $79.11.

Davita (NYSE:DVA) last issued its quarterly earnings data on Wednesday, February 13th. The company reported $0.90 EPS for the quarter, beating the Zacks’ consensus estimate of $0.89 by $0.01. The business had revenue of $2.82 billion for the quarter, compared to analyst estimates of $2.97 billion. Davita had a return on equity of 13.75% and a net margin of 1.40%. The firm’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.92 EPS. Research analysts expect that Davita Inc will post 4.67 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2019/02/15/davita-inc-dva-shares-sold-by-cognios-capital-llc.html.

Davita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Read More: What are different types of coverage ratios?

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.